Updating MISEV: Evolving the minimal requirements for studies of extracellular vesicles
- PMID: 34953156
- PMCID: PMC8710080
- DOI: 10.1002/jev2.12182
Updating MISEV: Evolving the minimal requirements for studies of extracellular vesicles
Abstract
The minimal information for studies of extracellular vesicles (EVs, MISEV) is a field-consensus rigour initiative of the International Society for Extracellular Vesicles (ISEV). The last update to MISEV, MISEV2018, was informed by input from more than 400 scientists and made recommendations in the six broad topics of EV nomenclature, sample collection and pre-processing, EV separation and concentration, characterization, functional studies, and reporting requirements/exceptions. To gather opinions on MISEV and ideas for new updates, the ISEV Board of Directors canvassed previous MISEV authors and society members. Here, we share conclusions that are relevant to the ongoing evolution of the MISEV initiative and other ISEV rigour and standardization efforts.
Keywords: MISEV; ectosomes; exosomes; extracellular vesicles; microvesicles; reproducibility; rigor; standardization.
© 2021 The Authors. Journal of Extracellular Vesicles published by Wiley Periodicals, LLC on behalf of the International Society for Extracellular Vesicles.
Conflict of interest statement
EIB: Advisory board of Sphere Gene Therapeutics Inc.; JL: owns stock in Codiak BioSciences; ownership in Exocure biosciences Inc.; consults in the EV field through Vesiclebio AB; DCIG: Consultancy agreement with Codiak BioSciences.
Figures
References
-
- Börger, V. , Weiss, D. J. , Anderson, J. D. , Borràs, F. E. , Bussolati, B. , Carter, D. R. F. , Dominici, M. , Falcón‐Pérez, J. M. , Gimona, M. , Hill, A. F. , Hoffman, A. M. , de Kleijn, D. , Levine, B. L. , Lim, R. , Lötvall, J. , Mitsialis, S. A. , Monguió‐Tortajada, M. , Muraca, M. , Nieuwland, R. , … Giebel, B. (2020). International Society for Extracellular Vesicles and International Society for Cell and Gene Therapy statement on extracellular vesicles from mesenchymal stromal cells and other cells: Considerations for potential therapeutic agents to suppress coronavir. Cytotherapy, 22(9), 482–485. - PMC - PubMed
-
- Clayton, A. , Boilard, E. , Buzas, E. I. , Cheng, L. , Falcón‐Perez, J. M. , Gardiner, C. , Gustafson, D. , Gualerzi, A. , Hendrix, A. , Hoffman, A. , Jones, J. , Lässer, C. , Lawson, C. , Lenassi, M. , Nazarenko, I. , O'Driscoll, L. , Pink, R. , Siljander, P. R. M. , Soekmadji, C. , … Nieuwland, R. (2019). Considerations towards a roadmap for collection, handling and storage of blood extracellular vesicles. Journal of Extracellular Vesicles [Internet], 2019 Dec 1 [cited 2020 Jul 28]; 8(1), 1647027. Available from: https://pubmed.ncbi.nlm.nih.gov/31489143/ - PMC - PubMed
-
- Erdbrügger, U. , Blijdorp, C. J. , Bijnsdorp, I. V. , Borràs, F. E. , Burger, D. , Bussolati, B. , Byrd, J. B. , Clayton, A. , Dear, J. W. , Falcón‐Pérez, J. M. , Grange, C. , Hill, A. F. , Holthöfer, H. , Hoorn, E. J. , Jenster, G. , Jimenez, C. R. , Junker, K. , Klein, J. , Knepper, M. A. , … Martens‐Uzunova, E. S. (2021). Urinary extracellular vesicles: A position paper by the Urine Task Force of the International Society for Extracellular Vesicles. Journal of Extracellular Vesicles [Internet]. 2021 May 1 [cited 2021 Oct 3], 10(7), e12093. Available from: https://pubmed.ncbi.nlm.nih.gov/34035881/ - PMC - PubMed
-
- Lotvall, J. , Hill, A. F. , Hochberg, F. , Buzas, E. I. , Di Vizio, D. , Gardiner, C. , Gho, Y. S. , Kurochkin, I. V. , Mathivanan, S. , Quesenberry, P. , Sahoo, S. , Tahara, H. , Wauben, M. H. , Witwer, K. W. , & Théry, C. (2014). Minimal experimental requirements for definition of extracellular vesicles and their functions: A position statement from the International Society for Extracellular Vesicles. Journal of Extracellular Vesicles [Internet], 3, 26913. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25536934 - PMC - PubMed
Publication types
MeSH terms
Grants and funding
- BB/K017462/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
- MH118164/NH/NIH HHS/United States
- R33 MH118164/MH/NIMH NIH HHS/United States
- 28123/CRUK_/Cancer Research UK/United Kingdom
- R01 AI144997/AI/NIAID NIH HHS/United States
- R01 CA234557/CA/NCI NIH HHS/United States
- UH3 CA241694/CA/NCI NIH HHS/United States
- DA047807/NH/NIH HHS/United States
- BB/R004862/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
- AI144997/NH/NIH HHS/United States
- R01 CA218526/CA/NCI NIH HHS/United States
- CA241694/NH/NIH HHS/United States
- R21 MH118164/MH/NIMH NIH HHS/United States
- R01 DA047807/DA/NIDA NIH HHS/United States
- R01 DK125856/DK/NIDDK NIH HHS/United States
- UG3 CA241694/CA/NCI NIH HHS/United States
- R01 HL140469/HL/NHLBI NIH HHS/United States
- C19591/A19076/CRUK_/Cancer Research UK/United Kingdom
- R01 HL148786/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
